Home > Press > Raymor Closes Private Placement of $ 2,400,000 with Premier US Financial Institution
Abstract:
Raymor Industries Inc. (TSX VENTURE:RAR), a leading developer and producer of single-walled carbon nanotubes, nanomaterials and advanced materials, is pleased to announce that the company has completed a private placement for 2,000,000 units (the "Units"), representing proceeds of $2,400,000, subject to the approval of the regulatory authorities having jurisdiction over the securities of the Company.
Each Unit consists of one common share at a price of $1.195 per common share, one quarter (1/4) of one Series "A" share purchase warrant (a "Series A Warrant") at a price of $0.0025 per Series "A" Warrant and one quarter (1/4) of one Series "B" share purchase warrant (a "Series B Warrant") at a price of $0.0025 per Series "B" Warrant. Each whole Series "A" Warrant shall entitle its holder thereof to purchase one (1) additional common share of the share capital of the Corporation at a price of $1.55 for a period of twelve (12) months from the closing date. Each whole Series "B" Warrant shall entitle its holder thereof to purchase one (1) additional common share of the share capital of the Corporation at a price of $1.75 for the period which is between the twelfth (12th) and eighteenth (18th) month following the closing date.
The securities issued under the private placement are subject to a four-month hold period, expiring on September 13, 2007.
The proceeds of the private placement will be used to augment single-walled carbon nanotubes (C-SWNT) production capacity, for the acquisition of additional equipment in the metallic powders and coatings division and for working capital.
Commenting on the news above, Mr. Stephane Robert, President and CEO of Raymor Industries said the following:
"The closing of this financing will allow Raymor to be more aggressive in growing each division of our company. This institution's participation will continue to increase Raymor's visibility in the US and Canadian financial communities."
####
About Raymor Industries Inc.
RAYMOR INDUSTRIES INC. (TSX VENTURE:RAR) has as its mission to become a leading developer of high technology for the production of single-walled carbon nanotubes, nanomaterials and other advanced materials for high value-added applications. Raymor Industries operates three wholly-owned, industrial subsidiaries, Raymor Nanotech, Raymor Aerospace and AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and comprising four divisions: (1) nanotechnology products, including nano-powders, nano-coatings, and single-walled carbon nanotubes (C-SWNT) for "the applications of tomorrow"; (2) thermal spray coatings, which largely targets military, aeronautical, aerospace, specialized industrial, and mining applications; (3) spherical metallic powders, primarily used for biomedical and aerospace applications; and (4) net-shape forming, a component manufacturing technique used for ballistic protection and other aerospace and military applications. Raymor holds the exclusive rights to more than 20 patents throughout the world, with other patents pending.
ON BEHALF OF THE BOARD OF DIRECTORS
Stephane Robert, President.
FOR MORE INFORMATION ON RAYMOR INDUSTRIES, A NANOTECH 100 COMPANY AND LIST OF NANOTECH 100 COMPILED BY IANANO, PLEASE VISIT: http://www.raymor.com
(VERSION FRANCAISE SERA DISPONIBLE SUR LE SITE WEB DE RAYMOR)
For more information, please click here
Contacts:
Raymor Industries Inc.
Investor Relations
450-434-1004 ext.: 444
Toll Free: 888-734-1004
450-434-1300 (FAX)
or
Raymor Industries Inc.
Media Relations
Copyright © CCNMatthews
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||